MENU
ITRM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Iterum Therapeutics (ITRM) Ownership - Who owns Iterum Therapeutics?

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally... Show more

Profile

Industry
N/A
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.05M
P/E Ratio
N/A
Total Cash
11M
Projected Growth
N/A
Total Debt
33.74M
Revenue
390K
Risk (Beta)
4.86
Dividend Yield
N/A
Total Cash/Share
0.21
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price

Fundamentals

ITRM
Capitalization
N/A
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
N/A
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
N/A
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
N/A
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com